WDFY2 and breast cancer: We also analysed an additional RNA-seq dataset from different subtypes of breast cancers (ER+ and TNBCs) in comparison with the adjacent normal tissues, highlighting a significant reduction in WDFY2 in ER+ but not in TNBCs (Supplementary Figure S4E).